All News

Please empower your patients, Whats important to you patient is certainly not important to you!!! Please listen and help with the pain struggle!! @RheumNow #Rnl2022 https://t.co/xaLj1eTnCj

“Get together to discuss difficult cases through case conferences, referrals to colleagues as second opinions, go to conferences, etc” @RheumNow #RNL2022

“Shared decision making helps with patient compliance.” @RheumNow #RNL2022 Do you see this as a benefit to shared decision making? I do!

Shared decision making is a key!! @RheumNow #Rnl2022 Data shows more compliance !! which is a key in managing chronic illnesses. https://t.co/ZuJMd4Bd9c

Do you use shared decision making in your clinic? #RNL2022 @RheumNow

@RheumNow #RNL2022 https://t.co/wCb0mPBMjA

Have you heard the term "Pharmionics?" It's the study about how ambulatory patients use and misuse prescription drugs. In most clinics, DMARD adherence is around 50% or less. Dr. Kaleb Michaud #RNL2022 @RheumNow

Let's start with difficult to treat RA Seronegative RA should be an opportunity to reconsider the diagnosis🤔 @RheumNow #RNL2022 https://t.co/EZhrk0b40E

For RA patients who've failed multiple DMARDs and biologics, it may be time to "Ctrl-Alt-Del" reset and consider 1) what tx pt failed? 2) what will the pt NOT take 3) did any tx help? @RheumNow #RNL2022 https://t.co/VhXkN9j9IO

Some RA phenotypes, One day will have OA phenotypes. @RheumNow #Rnl2022 https://t.co/rVb6cfqSTZ

Comprehensive table on what therapies to avoid based on co-morbidities. Excellent talk by Dr. Cush! @RheumNow #RNL2022 https://t.co/GaTH3ftfjT

Whats your MTX day or whats your injection date ?! always help to know how adherent your patient is to once weekly medications ?! @RheumNow #Rnl2022 Great talk by @Dr_K https://t.co/b7R1NpgeTc

Can we predict which patient respond to which treatment?! Seropositivity? True for Rituximab and Abatacept! what about seronegative ? @RheumNow #Rnl2022 Amazing talk by Ernest choy. https://t.co/NHosJrQ8yG

Heterogeneous pathology leads to heterogeneous response to treatment! Synovium plasma gene expression🤓 Precision and rheumatology! Ernest Choy @RheumNow #Rn12022 https://t.co/E2j2oD3RaA

Precision medicine in RA. Synovial biopsy and synovial molecular signature can predict radiographic progression @RheumNow #RNL2022 https://t.co/7WPGVhRMD5

Not bacteria it self, the metabolic changes ( heat map) predict response to treatment! Very interesting 🤓. NSAIDS change the microbiota😲, didn't see that coming ! @RheumNow Ernest Chiy #Rnl2022 https://t.co/QQoubmVRsn

Dr. Ernest Choy on how gut microbiome can affect RA prognosis and treatment Our gut microbiota can be changed by diet and medications (NSAIDs) @RheumNow #RNL2022 https://t.co/Cp19kG3z8D

3 different Pathotypes at level of synovium and treatment decision! Sunovium signature, identify signature for response to treatment ▶️ CXCL13 IL 6 ▶️ ICAM TNF @RheumNow Ernest Choy #Rnl2022 https://t.co/252fYM1PnY

Is it really seronegative RA!!!! Happening now. #RnI2022 @RheumNow https://t.co/R3UTYuZRvJ

“best laid plans of mice and men oft go astray”. Dr. Cush giving his opening remarks and pod at #Rnl2022 https://t.co/o9lenN1Dkd

Topics

All News

Do you get our email newsletter?